» Articles » PMID: 35047467

Regressing SARS-CoV-2 Sewage Measurements Onto COVID-19 Burden in the Population: A Proof-of-Concept for Quantitative Environmental Surveillance

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA virus, a member of the coronavirus family of respiratory viruses that includes severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and the Middle East respiratory syndrome (MERS). It has had an acute and dramatic impact on health care systems, economies, and societies of affected countries during the past 8 months. Widespread testing and tracing efforts are being employed in many countries in attempts to contain and mitigate this pandemic. Recent data has indicated that fecal shedding of SARS-CoV-2 is common and that the virus RNA can be detected in wastewater. This indicates that wastewater monitoring may provide a potentially efficient tool for the epidemiological surveillance of SARS-CoV-2 infection in large populations at relevant scales. In particular, this provides important means of (i) estimating the extent of outbreaks and their spatial distributions, based primarily on in-sewer measurements, (ii) managing the early-warning system quantitatively and efficiently, and (iii) verifying disease elimination. Here we report different virus concentration methods using polyethylene glycol (PEG), alum, or filtration techniques as well as different RNA extraction methodologies, providing important insights regarding the detection of SARS-CoV-2 RNA in sewage. Virus RNA particles were detected in wastewater in several geographic locations in Israel. In addition, a correlation of virus RNA concentration to morbidity was detected in Bnei-Barak city during April 2020. This study presents a proof of concept for the use of direct raw sewage-associated virus data, during the pandemic in the country as a potential epidemiological tool.

Citing Articles

Detection of biological loads in sewage using the automated robot-driven photoelectrochemical biosensing platform.

Zhang Y, Chen Z, Wei S, Zhang Y, Fu H, Zhang H Exploration (Beijing). 2024; 4(5):20230128.

PMID: 39439495 PMC: 11491307. DOI: 10.1002/EXP.20230128.


Inter-institutional laboratory standardization for SARS-CoV-2 surveillance through wastewater-based epidemiology applied to Mexico City.

Oyervides-Munoz M, Aguayo-Acosta A, De Los Cobos-Vasconcelos D, Carrillo-Reyes J, Espinosa-Garcia A, Campos E IJID Reg. 2024; 12:100429.

PMID: 39318545 PMC: 11419891. DOI: 10.1016/j.ijregi.2024.100429.


Analytical validation of a semi-automated methodology for quantitative measurement of SARS-CoV-2 RNA in wastewater collected in northern New England.

Robbins A, Gallagher T, Toledo D, Hershberger K, Salmela S, Barney R Microbiol Spectr. 2024; 12(6):e0112223.

PMID: 38747589 PMC: 11323974. DOI: 10.1128/spectrum.01122-23.


The role of wastewater treatment plants as tools for SARS-CoV-2 early detection and removal.

Lesimple A, Jasim S, Johnson D, Hilal N J Water Process Eng. 2024; 38:101544.

PMID: 38620686 PMC: 7377730. DOI: 10.1016/j.jwpe.2020.101544.


Coronavirus 2 (SARS-CoV-2) in water environments: Current status, challenges and research opportunities.

Ihsanullah I, Bilal M, Naushad M J Water Process Eng. 2024; 39:101735.

PMID: 38620601 PMC: 7566827. DOI: 10.1016/j.jwpe.2020.101735.


References
1.
La Rosa C, Longmate J, Lacey S, Kaltcheva T, Sharan R, Marsano D . Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant. J Infect Dis. 2012; 205(8):1294-304. PMC: 3308906. DOI: 10.1093/infdis/jis107. View

2.
Wu F, Zhang J, Xiao A, Gu X, Lee W, Armas F . SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases. mSystems. 2020; 5(4). PMC: 7566278. DOI: 10.1128/mSystems.00614-20. View

3.
Ye Y, Ellenberg R, Graham K, Wigginton K . Survivability, Partitioning, and Recovery of Enveloped Viruses in Untreated Municipal Wastewater. Environ Sci Technol. 2016; 50(10):5077-85. DOI: 10.1021/acs.est.6b00876. View

4.
Carducci A, Morici P, Pizzi F, Battistini R, Rovini E, Verani M . Study of the viral removal efficiency in a urban wastewater treatment plant. Water Sci Technol. 2008; 58(4):893-7. DOI: 10.2166/wst.2008.437. View

5.
Qiu Y, Lee B, Neumann N, Ashbolt N, Craik S, Maal-Bared R . Assessment of human virus removal during municipal wastewater treatment in Edmonton, Canada. J Appl Microbiol. 2015; 119(6):1729-39. DOI: 10.1111/jam.12971. View